Polc P, Haefely W
Naunyn Schmiedebergs Arch Pharmacol. 1976 Aug;294(2):121-31. doi: 10.1007/BF00507844.
The effects of diazepam, flunitrazepam, phenobarbitone and baclofen on excitatory as well as on pre- and postsynaptic inhibitory processes in the cuneate nucleus were studied in decerebrate cats. Afferent presynaptic inhibition in the cuneate nucleus, evoked by volleys in the median nerve, and assessed by the size of the positive cuneate surface potential (P wave), the dorsal column reflex (DCR), and the increased excitability of primary afferent terminals of the ulnar nerve, was markedly enhanced by diazepam (0.1-3.0 mg/kh i.v.) and flunitrazepam (0.01-0.3 mg/kg i.v.), slightly enhanced by lower doses of phenobarbitone (3-20 mg/kg i.v.), but depressed by baclofen (1-10 mg/kg i.v.). Diazepam, flunitrazepam and phenobarbitone also increased postsynaptic inhibition in the cuneate nucleus which was measured by the decrease after conditioning volleys in the median nerve of the short-latency lemniscal response to cuneate stimulation. The GABA receptor blocking agent, picrotoxin, antagonized the effects of diazepam on pre- and postsynaptic inhibition in a surmountable way. After thiosemicarbazide (TSC), an inhibitor of GABA synthesis, both pre- and postsynaptic inhibition were greatly reduced and the augmenting effect of diazepam on both types of inhibition was nearly abolished. Aminooxyacetic acid (AOAA), an inhibitor of GABA degradation, slightly enhanced pre- and postsynaptic inhibition; the effects of diazepam were unaffected by AOAA. Diazepam, flunitrazepam and phenobarbitone did not alter the resting excitability of primary afferent endings or of cuneo-thalamic relay (CTR) cells in the cuneate nucleus. After higher doses (30 mg/kg i.v.) of phenobarbitone pre- and postsynaptic inhibition, which were enhanced by 10 mg/kg of this drug, tended to return to pre-drug values or below. Phenobarbitone, in contrast to benzodiazepines, also depressed in a dose-dependent way the N wave, which is an index of the orthodromic excitation of the CTR cells. Baclofen strongly depressed the cuneate N wave, decreased the excitability of CTR cells, reduced pre- and postsynaptic inhibition, but had no effect on the resting excitability of primary afferent endings. Our findings suggest the following modes of action of the above mentioned drugs: 1. benzodiazepines enhance selectively the GABA-mediated pre- and postsynaptic inhibition in the cuneate nucleus; 2. phenobarbitone slightly enhances pre- and postsynaptic inhibition only in a narrow dose range, and in addition reduces the excitatory processes in the cuneate nucleus; 3. baclofen seems to depress the excitation of cuneate relay cells and interneurones postsynaptically; the depression of relay cells is probably nonspecific.
在去大脑猫中研究了地西泮、氟硝西泮、苯巴比妥和巴氯芬对楔束核中兴奋性以及突触前和突触后抑制过程的影响。由正中神经冲动诱发的楔束核传入性突触前抑制,通过楔束表面正电位(P波)、背柱反射(DCR)的大小以及尺神经初级传入终末兴奋性的增加来评估,地西泮(0.1 - 3.0毫克/千克静脉注射)和氟硝西泮(0.01 - 0.3毫克/千克静脉注射)可使其显著增强,低剂量苯巴比妥(3 - 20毫克/千克静脉注射)使其轻度增强,但巴氯芬(1 - 10毫克/千克静脉注射)使其降低。地西泮、氟硝西泮和苯巴比妥还增加了楔束核中的突触后抑制,这是通过在对楔束刺激的短潜伏期lemniscal反应的正中神经条件性冲动后测量其降低来确定的。GABA受体阻断剂苦味毒以可克服的方式拮抗地西泮对突触前和突触后抑制的作用。在硫代氨基脲(TSC)(一种GABA合成抑制剂)作用后,突触前和突触后抑制均大大降低,地西泮对两种类型抑制的增强作用几乎被消除。氨基氧乙酸(AOAA)(一种GABA降解抑制剂)轻度增强突触前和突触后抑制;地西泮的作用不受AOAA影响。地西泮、氟硝西泮和苯巴比妥不会改变楔束核中初级传入末梢或楔束 - 丘脑中继(CTR)细胞的静息兴奋性。在较高剂量(30毫克/千克静脉注射)的苯巴比妥作用后,由10毫克/千克该药物增强的突触前和突触后抑制倾向于恢复到用药前的值或更低。与苯二氮䓬类药物相反,可以剂量依赖性方式抑制N波,N波是CTR细胞顺向兴奋的指标。巴氯芬强烈抑制楔束N波,降低CTR细胞的兴奋性,减少突触前和突触后抑制,但对初级传入末梢的静息兴奋性没有影响。我们的研究结果提示上述药物的以下作用方式:1. 苯二氮䓬类药物选择性增强楔束核中GABA介导的突触前和突触后抑制;2. 苯巴比妥仅在狭窄剂量范围内轻度增强突触前和突触后抑制,此外还减少楔束核中的兴奋过程;3. 巴氯芬似乎在突触后抑制楔束中继细胞和中间神经元的兴奋;对中继细胞的抑制可能是非特异性的。